Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Ethical guidelines for deliberately infecting volunteers with COVID-19

Tools
- Tools
+ Tools

Richards, Adair D. (2020) Ethical guidelines for deliberately infecting volunteers with COVID-19. Journal of Medical Ethics, 46 (8). pp. 502-504. doi:10.1136/medethics-2020-106322

[img]
Preview
PDF
WRAP-Ethical-guidelines-for-deliberately-infecting-volunteers-with-COVID-19-Richards-22.pdf - Accepted Version - Requires a PDF viewer.
Available under License Creative Commons: Attribution-Noncommercial 4.0.

Download (250Kb) | Preview
Official URL: http://dx.doi.org/10.1136/medethics-2020-106322

Request Changes to record.

Abstract

Global fatalities related to COVID-19 are expected to be high in 2020–2021. Developing and delivering a vaccine may be the most likely way to end the pandemic. If it were possible to shorten this development time by weeks or months, this may have a significant effect on reducing deaths. Phase II and phase III trials could take less long to conduct if they used human challenge methods—that is, deliberately infecting participants with COVID-19 following inoculation. This article analyses arguments for and against such methods and provides suggested broad guidelines for regulators, researchers and ethics committees when considering these matters. It concludes that it may be possible to maintain current ethical standards yet still permit human challenge trials in a context where delay is critical. The implications are that regulators and researchers need to work together now to design robust but short trials and streamline ethics approval processes so that they are in place when applications for trials are made.

Item Type: Journal Item
Subjects: R Medicine > R Medicine (General)
R Medicine > RA Public aspects of medicine
Divisions: Faculty of Science, Engineering and Medicine > Science > Chemistry
Library of Congress Subject Headings (LCSH): COVID-19 (Disease), COVID-19 (Disease) -- Prevention, COVID-19 (Disease) -- Research -- Moral and ethical aspects, Medical ethics , Clinical trials -- Moral and ethical aspects, Human experimentation in medicine -- Moral and ethical aspects
Journal or Publication Title: Journal of Medical Ethics
Publisher: BMJ Group
ISSN: 0306-6800
Official Date: August 2020
Dates:
DateEvent
August 2020Published
27 May 2020Available
16 May 2020Accepted
17 April 2020Submitted
Volume: 46
Number: 8
Page Range: pp. 502-504
DOI: 10.1136/medethics-2020-106322
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Date of first compliant deposit: 26 July 2022
Date of first compliant Open Access: 26 July 2022

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us